Roboligent
Roboligent develops AI-powered soft robotics platforms: ROBIN, a mobile bimanual humanoid for smart factory automation, and REGEN, a 7-DOF force-controlled rehabilitation device, sold to manufacturers, hospitals, and U.S. defense agencies.
- Company typePrivate
- Founded2017
- HeadquartersRound Rock, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Roboligent does
Roboligent Inc. is a private U.S. robotics company, founded in 2016–2017 and headquartered in Round Rock, Texas, that develops AI-powered soft-robotics platforms built around precision force-control actuators. Its commercial portfolio comprises two products: ROBIN, a mobile bimanual humanoid robot combining autonomous mobile robot navigation with dual-arm soft manipulation for smart factory machine tending, teleoperation, logistics, and warehouse tasks; and REGEN, a 7-DOF force-controlled medical rehabilitation device that automates physical therapy using Teach-and-Follow programming and an Assist-as-Needed protocol for stroke and neuromuscular patients. Both products rely on imitation learning, computer vision, and multimodal AI to enable safe human-robot interaction and rapid task adaptation from demonstration.
The company's revenue model is a mix of capital equipment hardware sales (ROBIN to manufacturers, REGEN to hospitals and rehabilitation centers), U.S. government R&D contracts via the SBIR/STTR programs (notably AFWERX), and potential licensing of its force-control and soft manipulator patents. Go-to-market is sales-led and enterprise-oriented: direct field sales to U.S. manufacturers, healthcare institutions, and defense agencies for ROBIN and REGEN respectively, augmented by strategic partnerships with Korean firms (Tesollo, Aidin Robotics, Goseong Engineering) for joint product development and Asian/North American market entry, and by ecosystem relationships with Johnson & Johnson JLABS @ TMC, UT Austin, Texas Medical Center Innovation, and Changi General Hospital (Singapore). Customer concentration is high, anchored on the $1.8M AFWERX STTR Phase II contract (Sep 2024–2026) and a small number of PoC and pipeline relationships, with mass-production verification of ROBIN underway with a major Korean conglomerate as of late 2025.
Roboligent firmographics
Firmographics- Name
- Roboligent
- Legal name
- Roboligent Inc.
- Website
- https://roboligent.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Roboligent develops AI-powered soft robotics platforms: ROBIN, a mobile bimanual humanoid for smart factory automation, and REGEN, a 7-DOF force-controlled rehabilitation device, sold to manufacturers, hospitals, and U.S. defense agencies.
- Ownership category
- akta.pro rank
Where Roboligent is headquartered
LocationHeadquarters
- HQ city
- Round Rock
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Roboligent business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Humanoid Robot Sales (ROBIN): Sale of ROBIN mobile humanoid robots for smart factory automation, including machine tending, teleoperation, and logistics applications. Revenue is generated through direct enterprise sales of robotic systems.
- Rehabilitation Robot Sales (REGEN): Sale of REGEN robotic rehabilitation systems to hospitals, clinics, and rehabilitation centers. Regen is a medical device designed for clinical environments, operated by qualified technicians or therapists.
- Government / Defense Contracts (STTR/SBIR): Revenue from U.S. Department of the Air Force STTR Phase II contract ($1.8MM) focused on advanced robotic-assisted rehabilitation technology. The goal is preferential deployment to US military hospitals after project completion.
- Licensing / Technology Partnerships: Revenue potential through licensing of proprietary force-control technology, soft manipulator patents, and co-development partnerships with strategic partners for global market expansion.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | No public pricing available |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Roboligent product offering
Product offeringCore offering
Roboligent designs and sells AI-powered mobile humanoid robots built on patented soft-robotics and force-control technology. Its two flagship products are ROBIN, a mobile bimanual humanoid for smart-factory automation (machine tending, logistics, teleoperation), and REGEN, a 7-DOF force-controlled medical device that automates physical therapy exercises for patients with neuromuscular impairments.
Product overview
Roboligent develops AI-powered mobile manipulator robots (humanoid robots) that seamlessly integrate with human workflows for manufacturing and healthcare applications. The product portfolio centers on two core platforms: ROBIN, a mobile bimanual humanoid robot for smart factory automation including machine tending, logistics, and warehouse operations; and REGEN, a rehabilitation robot for automating physical therapy exercises. Both products leverage proprietary force-controlled 'soft robot' technology and AI capabilities including imitation learning, autonomous navigation, and computer vision for adaptive, safe human-robot interaction.
Differentiator
Problem solved
Functional benefit
Brands
- ROBIN: Mobile humanoid robot with soft robot and imitation learning technology, designed for smart factory automation with AI-driven navigation, object recognition, and bimanual manipulation capabilities.
- REGEN
Products and services
- ROBIN ROBIN is an AI-powered mobile bimanual humanoid robot with patented soft robotics and force-controlled actuators, built for manufacturing automation, machine tending, material handling, teleoperation, and warehouse logistics. It uses imitation learning so operators can teach tasks by demonstration, enabling safe human-robot collaboration without cages.
- REGEN REGEN is a medical device that automates physical therapy exercises for patients with neuromuscular impairments. It features a 7-degree-of-freedom force-controlled robot covering a full 6D motional space, supports upper-limb, lower-limb, and gait training, uses Teach-and-Follow programming and an Assist-as-Needed (AAN) protocol, and provides quantitative, data-driven progress tracking for clinical environments operated by therapists and technicians.
Quantifiable outcome
- 60% Therapy Intensity Increase
- +2 more outcomes
Companies that use Roboligent
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles3 records
Roboligent technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature8 records
Roboligent partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and major.
- Aidin RoboticscoreStrategic partnership for joint product development, component supply and solution co-creation, and global market expansion. Aidin Robotics brings high-performance, cost-competitive force/torque sensors and humanoid robot parts, while Roboligent contributes AI and soft manipulation technology. Both companies plan cross-sales and joint marketing efforts, aiming to position themselves among Top Tier robotics companies worldwide.
- TesollocoreRoboligent signed a Memorandum of Understanding (MoU) with Tesollo, a robot hand-based automation solutions specialist. The partnership aims to develop innovative robot solutions by combining Roboligent's AI-based precision flexible robot arm technology with Tesollo's multi-DOF human-like robot hand technology. Cooperation areas include technology sharing and joint research, product portfolio expansion, and global market expansion collaboration across Asia and North America. The partnership resulted in a joint showcase at RobotWorld 2025.
- Goseong EngineeringcoreGoseong Engineering made a strategic investment in Roboligent to develop AI-integrated robots and expand into overseas smart factory markets, particularly North America. The collaboration combines Goseong's automation solutions with Roboligent's force control technology. Goseong also plans to establish smart factories in the U.S. as part of its expansion strategy.
- Johnson & Johnson Innovation – JLABS @ TMCcoreRoboligent was selected as a resident company of JLABS @ TMC (Texas Medical Center), a global network of open innovation ecosystems. The residency is intended to accelerate the innovation and commercialization of Roboligent's first commercialized product, the Regen rehabilitation therapy automation robot.
- University of Texas at Austin / Human Centered Robotics LabcoreCollaboration with the Human Centered Robotics laboratory at the University of Texas to develop advanced rehabilitation control policies using supervised machine learning techniques for the AFWERX STTR project.
- Changi General Hospital (Singapore)majorJoint project in pipeline with Changi General Hospital in Singapore for robotic rehabilitation technology deployment. Part of Roboligent's commercialization strategy driven by public sectors in the US, Korea, and Singapore.
- Texas Medical Center (TMC) InnovationcoreTMC Innovation is a partner supporting Roboligent through the JLABS residency, providing access to the world's largest medical city ecosystem for healthcare robotics development and commercialization.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Roboligent competitors and assessment
Company assessmentDirect peers
- Apptronik: Austin, Texas-based humanoid robotics company building general-purpose humanoids (Apollo) for industrial and manufacturing applications. Direct competitor in the same geography targeting the same factory-automation use case as Roboligent's ROBIN.
- 1X Technologies: Norwegian humanoid robotics company developing NEO, a bipedal humanoid for home and commercial service applications. Direct competitor in AI-driven humanoid manipulation with backing from OpenAI.
- Hocoma (DIH Medical): Swiss-based global leader in robotic and sensor-based rehabilitation devices (Lokomat, Armeo) for clinical and research use. Direct competitor to REGEN in the rehabilitation robotics space with established hospital installed base and FDA clearances.
- Ekso Bionics: Niche rehabilitation and exoskeleton company developing robotic devices for stroke and spinal cord injury rehabilitation, including the EksoNR. Direct competitor to REGEN in robotic rehabilitation therapy for clinical settings.
- Sanctuary AI: Canadian developer of Phoenix, a general-purpose humanoid robot with Carbon AI control system, focused on industrial manipulation tasks. Direct competitor in AI-powered humanoid manipulation for labor-shortage applications.
- Fourier Intelligence: Shanghai/Singapore-based rehabilitation robotics company developing intelligent therapy robots for stroke and neuromuscular rehabilitation, including the GR-1 humanoid. Direct competitor to REGEN in rehabilitation robotics with established hospital footprint in Asia.
- Figure AI: Developer of the Figure 01/02 general-purpose humanoid robot aimed at manufacturing and warehouse labor-shortage applications. Direct competitor in industrial humanoid robotics with substantially more capital and partnerships (BMW, OpenAI).
- Agility Robotics: Creator of Digit, a bipedal humanoid robot focused on logistics and warehouse automation, with commercial deployments at Amazon and GXO. Direct peer in mobile manipulation for industrial settings.
Broad incumbents
- Tesla (Optimus): Tesla's humanoid robot program (Optimus) targets manufacturing labor automation within Tesla's own factories and eventually broader industrial use. Large incumbent competing for the same industrial humanoid opportunity as Roboligent's ROBIN, with vastly more capital and manufacturing capacity.
- Boston Dynamics: Established robotics pioneer (Spot, Stretch, Atlas) with broader industrial and research portfolio owned by Hyundai. Competitor in mobile manipulation and humanoid robotics but operates across many verticals beyond Roboligent's smart-factory and rehabilitation focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Roboligent social profiles
Digital presenceRoboligent financial estimates
Financial estimateRevenue estimate
Valuation estimate
Roboligent leadership team
Management profileNumber of profiles
Profiles1 record
Roboligent funding detail
Funding detailFunding overview
Funding rounds10 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Roboligent M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Roboligent
What does Roboligent do?
Roboligent designs and sells AI-powered mobile humanoid robots built on patented soft-robotics and force-control technology. Its two flagship products are ROBIN, a mobile bimanual humanoid for smart-factory automation (machine tending, logistics, teleoperation), and REGEN, a 7-DOF force-controlled medical device that automates physical therapy exercises for patients with neuromuscular impairments.
Is Roboligent a public or private company?
Roboligent is a private company. It is classified as venture growth investor backed and is currently operating.
When was Roboligent founded?
Roboligent was founded in 2017. It employs 1 to 10 people.
Where is Roboligent based?
Roboligent is headquartered in Round Rock, United States, in the North America region.
How does Roboligent make money?
Four revenue lines are on record. Humanoid Robot Sales (ROBIN) is the primary driver. The others are rehabilitation Robot Sales (REGEN), government / Defense Contracts (STTR/SBIR) and licensing / Technology Partnerships.
Who are Roboligent's main competitors?
Direct peers on record are Apptronik, 1X Technologies, Hocoma (DIH Medical), Ekso Bionics, Sanctuary AI, Fourier Intelligence, Figure AI and Agility Robotics. Broad incumbents are Tesla (Optimus) and Boston Dynamics.
Does Roboligent have an API?
No public API is recorded for Roboligent.